Parabilis Medicines, Inc.

PBLS · Healthcare · Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for dis…

Parabilis Medicines, Inc. (PBLS), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 5 purchases and 0 sales, 1 filed past the deadline. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Jul 22 and filed Jul 22. The most active filer was Ra Capital Management, L.P. with 2 filings.

Add to watchlist

Filings, ttm

5 buys · 0 sells · 1 late

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$441.4M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 22

Filed Jul 22

ADViAverage daily dollar volume

$27.9M

market data

Share price · 12M

$38.43 (+21.6%)

Adjusted for splits and dividends.

Volume by month

Buys $441.4M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

RP Ra Capital Management, L.P. Director 2 filings AS

Alan Sebulsky Director 2 filings GL

Guy Levy 10% owner 1 filing

Recent filings

Ra Capital Management, L.P.PURCHASE Director $6.9M
244,593 sh across 6 lots
Exec Jul 20
Filed Jul 22 · 4:55 PM ET Guy LevyPURCHASE 10% owner $10.0M
500,000 sh across 2 lots
Exec Jun 11
Filed Jun 29 · 10:41 AM ET † Alan SebulskyPURCHASE Director $474K
17,500 sh across 3 lots
Exec Jun 12
Filed Jun 16 · 6:19 PM ET Ra Capital Management, L.P.PURCHASE Director $423.8M
21,188,750 sh across 2 lots
Exec Jun 11
Filed Jun 15 · 6:57 PM ET Alan SebulskyPURCHASE Director $250K
12,500 sh × $20.00
Exec Jun 11
Filed Jun 15 · 5:27 PM ET